Video

Lars Svensson from Cleveland Clinic: PARTNER Trials Continue to Provide Hope in Cardiovascular Surgery

Author(s):

Since its inception nearly a decade ago the PARTNER trials have shown new opportunities for cardiovascular disease patients to receive treatment they may not have been candidates for before.

Since its inception nearly a decade ago the PARTNER trials have shown new opportunities for cardiovascular disease patients to receive treatment they may not have been candidates for before.

Lars Svensson, MD, PhD, from the Cleveland Clinic discussed the latest results from the program, known as PARTNER 2 which was presented during the American College of Cardiology's 65th Annual Scientific Sessions in Chicago. Svensson said the most recent results have shown that not only can patients with severe cardiovascular conditions benefit from the newest surgical options but also those with more moderate health issues.

Related Videos
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
4 experts are featured in this series.
4 experts are featured in this series.
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
© 2024 MJH Life Sciences

All rights reserved.